The Bell2Bell (B2B) Podcast (podcast@investorbrandnetwork.com)

Bell2Bell’s latest podcast features Dr. Michael Dent, Founder, CEO and Chairman of HealthLynked Corp. (OTCQB: HLYK), a trailblazer in healthcare technology.

To begin the interview, Dent introduced HealthLynked’s business model.

“HealthLynked is a pioneering healthcare technology company focused on improving the efficiency and quality of healthcare through our advanced, integrated platform,” Dent said. “Our business model revolves around creating a global healthcare network that leverages artificial intelligence and an extensive healthcare dataset to provide personalized healthcare recommendations and streamline patient/provider interactions.”

“We offer an array of services, including online medical record storage, appointment scheduling, telemedicine and patient engagement tools. Our platform is designed to facilitate the exchange of medical information among healthcare practices, hospitals and emergency rooms, making it more accessible and efficient to both patients and providers.”

Dent then discussed his background prior to founding HealthLynked.

“I'm a physician by training… I attended medical school at the University of South Carolina in Charleston and then went on to my residency in obstetrics and gynecology at the University of Texas in Galveston. I came to Naples, Florida, where I started my practice focused mostly on high-risk obstetrics and minimally invasive surgery… In early 2001, I started a company called NeoGenomics Laboratories based in cancer diagnostics around genomics. I was the CEO many years there, and that became a global cancer diagnostics laboratory. I then founded HealthLynked, which is in the healthcare AI space, looking at how we can really improve healthcare for everybody globally around the world.”

Join IBN’s Stuart Smith and Dr. Michael Dent, Founder, CEO and Chairman of HealthLynked Corp., to learn more about HealthLynked’s recent milestones and the issues it’s addressing in the global healthcare industry.

To hear the episode and subscribe for future podcasts, visit https://podcast.bell2bell.com.

The latest installment of The Bell2Bell Podcast continues to reinforce IBN’s commitment to the expansion of its robust network of brands, client partners, followers, and the growing IBN Podcast Series. For more than 18 years, IBN has leveraged this commitment to provide unparalleled distribution and corporate messaging solutions to 500+ public and private companies.

To learn more about IBN’s achievements and milestones via a visual timeline, visit: https://IBN.fm/TimeLine

Bell2Bell’s latest podcast features Suchit Punnose, Founder & CEO of Modulex Modular Buildings Plc, a leading ConstrucTech company harnessing emerging technologies like AI, blockchain and IoT to efficiently meet burgeoning housing and infrastructure needs. PHP Ventures Acquisitions Corp. (Nasdaq: PPHPU) (Nasdaq: PPHP) (Nasdaq: PPHPR) (Nasdaq: PPHPW), a special purpose acquisition company, entered into a definitive business combination agreement pursuant to which it would merge with and into Modulex Modular Buildings Plc, a company registered in England and Wales with company number 0729166 (the "Target"), and Modulex Merger Sub, Cayman Islands exempted company and wholly-owned subsidiary of the Target ("Merger Sub”). Upon the closing of the business combination, which is expected in the second quarter of 2023, the combined company expects to remain listed on Nasdaq under the ticker symbol “MDLX”. 

Throughout the interview, Punnose discussed Modulex and how it is addressing the various issues facing the traditional construction industry. 

“Modulex is about delivering real estate version 2.0. To us, real estate version 2.0 is carbon-net-zero-certified buildings which are manufactured, not constructed. They are designed using AI with blockchain-based quality assurance and IoT-enabled smart features,” Punnose said. “All of those features encompass to us what future real estate version 2.0 stands for. It’s very topical for us to appreciate that, globally, there is a significant overhang in terms of demand for affordable housing, health care, student accommodation and various other real estate asset classes which are required in both developed economies and the global markets of the future. 

“In terms of the genesis of Modulex, we looked at the problems in the construction industry. Without construction, mankind can’t progress. We need infrastructure and everything from homes and hotels to schools. The key issues that we have in the traditional construction space are related to time and cost overruns, poor quality and its large carbon footprint. The solution to delivering the vast amount of buildings required for mankind to progress in terms of infrastructure, wellbeing and lifestyle is a pivot into modular buildings. Modular buildings are delivered with high speed and high quality on a fixed cost and time guarantee, and, with the relevant carbon-net-zero certification, they address the need of the hour.” 

Please see full terms of use and disclaimers on the InvestorBrandNetwork website, applicable to all content provided by IBN wherever published or re-published: http://ibn.fm/Disclaimer

Bell2Bell’s latest podcast features Louis Chen, the Executive Vice President and Chief Strategy Officer of Perfect Corp. (NYSE: PERF), which was founded in 2015 and has become an AI powerhouse for beauty and fashion brands. Developing such innovations as 'Beautiful AI', including Beauty AI, Skin AI, Fashion AI, and Generative AI SaaS solutions. The company has a strong lead in assisting top beauty brands in digital transformation, enhancing customer engagement, and driving sales growth while prioritizing sustainability and social responsibilities.

During the interview, Louis Chen discussed what makes Perfect Corp's approach to AI so unique.

"Perfect has a series of SAS software to help beauty and fashion brands through their e-commerce journey, by helping the consumer virtually try on products before they make the purchase, as well as skin care related technologies or other apparel and luxury items." The industry move to modernize the shopping experience places a direct emphasis on technological innovation, particularly in an era where you don't really have the beauty advisor in the store to help consumers anymore. Chen points out how Perfect hones in on this demand for enhanced product discovery and presentation, with advancements such as augmented reality playing a key role in helping the consumer localize and visualize the beauty, fashion and luxury brands they so desire.

Join IBN’s Carmel Fisher and Louis Chen, the Executive Vice President and Chief Strategy Officer of Perfect Corp. (NYSE: PERF), to learn more about the company. 

Please see full terms of use and disclaimers on the InvestorBrandNetwork website, applicable to all content provided by IBN wherever published or re-published: http://ibn.fm/Disclaimer

Bell2Bell’s latest podcast features Tamir Poleg, the Co-Founder, Chairman & CEO of The Real Brokerage Inc. (NASDAQ: REAX), which is revolutionizing the residential real estate industry by pairing best-in-class technology with the trusted guidance of an agent. We provide a digital brokerage platform for agents, while working to build a better end-to-end home buying experience for consumers.

During the interview, Tamir Poleg discussed what makes The Real Brokerage's business model so compelling.

"We are the most efficient real estate brokerage in the market because of the fact that we implement software instead of putting more and more humans to work, meaning that as we grow, as we scale, as we add more and more agents, we do not grow our operating expense at the same pace. And we have a very compelling ratio of one employee for every 140 agents, whereas the average in the industry is one employee for every 20 agents at any other brokerage. We have very few employees that process actions due to a lot of automation and software that we built that can automate all of the processes that typically are done by a human.So this is a huge competitive advantage because nobody can actually compete with us on efficiency and This is why we can scale just in the first two weeks of January of 2025, we added 1000 agents in two weeks."

Join IBN’s Carmel Fisher and Tamir Poleg, the Co-Founder, Chairman & CEO of The Real Brokerage Inc, to learn more about the company. 

Please see full terms of use and disclaimers on the InvestorBrandNetwork website, applicable to all content provided by IBN wherever published or re-published: http://ibn.fm/Disclaimer

Bell2Bell’s latest podcast features Beau Kelley, CEO of diversified real estate holding company Mountain Top Properties Inc. (OTC: MTPP), and Joseph Kelley, CEO of full service real estate management company On Site Builder Construction Co. Inc.

To begin the interview, Beau Kelley introduced Mountain Top Properties and its business model.

“This company is really focused on two main sectors, which are real estate/real property development and property technology,” Beau Kelley said. “We see that the property technology side of things is really a massive, growing opportunity to be able to expedite finance and payment methods and shipping routes and so many things that we can help out from a logistics standpoint. On the real estate side, this has been an opportunity that my father and I have talked about for a long time – bringing the capital markets opportunities into his building business.”

Joseph Kelley then discussed On Site Builder Construction and its history.

“We're approaching our 45th year building in the Hamptons. I've had the pleasure to work with some of the most renowned designers, interior designers and architects, building a custom home portfolio… Our houses have been highlighted in many publications and social media contacts and magazines and so forth. We have always had a tremendous reputation of building on time and on budget, even in the very high-end market.”

Beau Kelley then provided some insight into the real estate market of the Hamptons.

“The real estate market here is already a very well-known, high-end market… and there are not enough of these high-end homes available on the market to satisfy demand. So, although there are some opportunities to be able to redevelop existing projects, there are fantastic opportunities in ground-up homes. What we do is identify the lot and the area that we want to be in – waterfront and water view are really the premium areas to be. We're really looking forward to being able to get going with two or three projects in the new year, because we see that being just a fantastic way to build shareholder value and partner value over time.”

Join IBN’s Stuart Smith, CEO Beau Kelley of Mountain Top Properties Inc. and CEO Joseph Kelley of On Site Builder Construction Co. Inc. to learn more about the history of Mountain Top Properties.

To hear the episode and subscribe for future podcasts, visit https://podcast.bell2bell.com.

Bell2Bell’s latest podcast features Pat Ryan, Chairman and CEO of Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF), a critical metals separation technology company executing an ESG-centered plan toward establishing a comprehensive North American critical metals supply chain. 

To begin the interview, Ryan discussed the rising demand for critical metals and provided insight into how Ucore is working to limit Western reliance on Chinese supply chains. 

“Ucore Rare Metals is involved with critical metals separation technology. A lot of new 21st century tech – from wind energy to electric vehicles – is driven by critical metals,” Ryan said. “These critical metals are the things that make the batteries work – metals like lithium, cobalt and nickel – or electric vehicle motor components… made with rare earth elements and oxides… China has actually cornered the market on a lot of these materials, particularly rare earth elements and some of the battery metals. As you look at the global landscape, you’ve got to figure out ways to feed the North American and European opportunities… Ucore is focused on putting the hammer right on the nail in the mid-market of critical metal processing and refining.” 

Bell2Bell’s latest podcast features Irma Velazquez, MSc, CEO of Energy and Water Development Corp. (OTCQB: EAWD), a green-tech engineering solutions company focused on delivering water and energy to extreme environments.

To begin the interview, Velazquez discussed her background prior to joining Energy and Water Development Corp.

“I've been working with Energy and Water Development Corp. for more than 10 years. I previously worked with the United Nations for more than two decades before retiring to focus on green tech. I did this mainly because I realized the challenges that we will face, particularly in the countries where the greatest needs were already so visible. I decided to really focus on sustainable solutions for the supply of water, and this is why I joined Energy and Water Development Corp., to add my know-how and experience and understanding of different regions of the world.”

Bell2Bell’s latest podcast features Dr. Richard Lu, President and CEO of SolarBank Corporation (NASDAQ: SUUN) (Cboe CA: SUNN), a premier developer and owner of renewable and clean energy projects specializing in distributed and community solar initiatives throughout Canada and the United States.

During the interview, Lu discussed SolarBank’s business model and value proposition for investors.

“When you look at civilization over the years, originally, we depended on the sun to give us light for agriculture. Then, we relied on burning oil to break the darkness of the night. During industrialization, electricity allowed us to keep the lights on and now keeps us all connected. The driving force behind today’s digital economy is electricity. SolarBank is a clean and renewable power supplier focused on delivering electricity from non-emitting sources. That has been the mission and vision of the company for over 12 years.”

Lu also provided insight into the company’s current pipeline and near-term goals.

“We recently signed a $50 million USD contract with Qcells and are also building a 60 MWh battery storage project that we will own. As a vertically integrated company, we handle development, construction and ownership. Our pipeline includes solar, battery storage and EV charging projects totaling over 1 gigawatt of capacity across Canada and the U.S.”

“This year, we plan to continue delivering to the Honeywell portfolio with additional projects while fulfilling the Qcells contract. We are also expanding our portfolio with major infrastructure projects. Last year, through a $45 million valued all-stock deal, we acquired solar assets developed by our team over the past decade, which are now contributing to our recurring revenue. We currently own about $180 million in assets. In terms of revenue, we generated approximately $60 million in fiscal 2024, and, as of January, we have secured major contracts supporting our continued growth.”

Join IBN’s Carmel Fisher and Dr. Richard Lu, President and CEO of SolarBank Corporation, as they discuss SolarBank’s long-term goals and strategy for capitalizing on forecast growth, particularly in the data center industry.

To hear the episode and subscribe for future podcasts, visit https://podcast.bell2bell.com.

IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is excited to announce the release of the latest episode of The Bell2Bell Podcast, recorded live from the Alzheimer’s Association International Conference® 2024 (AAIC®) in Philadelphia. This release is part of IBN’s ongoing efforts to provide specialized content distribution via widespread syndication channels.

The Bell2Bell Podcast delivers informative updates and exclusive interviews with executives operating in fast-moving industries. Bell2Bell’s latest podcast features Dr. Maria Maccecchini, Ph.D., Founder, President, and CEO of Annovis Bio Inc. (NYSE: ANVS), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s disease (PD).

Broadcasting live from AAIC 2024, Dr. Maccecchini delves into the detailed findings from Annovis Bio’s recent Phase 2/3 Alzheimer’s study of its lead drug candidate, buntanetap. During the interview, she provides insights into how the scientific community is reacting to the promising data and what it could mean for the future of neurodegenerative disease treatment. Additionally, Dr. Maccecchini discusses Annovis Bio’s strategic plans moving forward, including potential regulatory milestones and upcoming clinical trials that aim to further validate the efficacy and safety of buntanetap in treating both Parkinson’s and Alzheimer’s diseases.

“Our Phase 2/3 data indicates that buntanetap has the potential to significantly improve the quality of life for early Alzheimer’s patients,” said Dr. Maccecchini during the interview. “Being able to share these findings live from AAIC, one of the most prestigious events in Alzheimer’s research, underscores the importance of our work and the promise it holds for patients.”

Join IBN’s Stuart Smith and Dr. Maria Maccecchini to learn more about Annovis Bio’s recent achievements, the next steps for buntanetap, and the company’s future goals.

To hear the episode and subscribe for future podcasts, visit https://podcast.bell2bell.com.

The latest installment of The Bell2Bell Podcast continues to reinforce IBN’s commitment to the expansion of its robust network of brands, client partners, followers, and the growing IBN Podcast Series. For more than 18 years, IBN has leveraged this commitment to provide unparalleled distribution and corporate messaging solutions to 500+ public and private companies.

To learn more about IBN’s achievements and milestones via a visual timeline, visit: https://IBN.fm/TimeLine

Bell2Bell’s latest podcast features Bruce Nurse, Head of Investor Relations for Vision Marine Technologies Inc. (NASDAQ: VMAR), a global leader and innovator within the performance electric recreational boating industry.

To begin the interview, Nurse introduced Vision Marine Technologies and its business model.

“Our objective here – our mission if you like – is really to disrupt the traditional boating industry by transforming the boating experience with electric power,” Nurse said. “We all see what's happening with the auto industry, with electrification of our vehicles. Every auto manufacturer now has an option for the consumer to drive electric, but we haven't seen this on the water.”

Bell2Bell’s latest podcast features Paul Gorman, CEO and Director of Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF), a strategic minerals company focused on locating and developing economic properties in the strategic metals and advanced materials space. 

To begin the interview, Gorman provided an introduction to the company’s business model and operating markets. 

“Reflex was really designed by a capital markets group taking a look at what was happening in North America pertaining to electrification. Whether you look at EVs or battery storage, there is a shift, and we wanted to be part of that,” Gorman said. “So, this capital markets group put together a very strong business plan and looked to put in a very strategic asset, the Ruby Graphite Mine located in southwest Montana. The reason that is very important is because, currently, there’s absolutely no graphite production in the United States, and it’s been that way for over 60 years.” 

The Bell2Bell’s latest audio production features Stormer Santana, Director of Sales for Dalmore Group, a tech-driven investment bank and broker dealer on a mission to revolutionize the way companies raise capital online.

To begin the interview, Santana discussed his reasons for working with Dalmore Group.

“We focus on online fundraising. So, as Director of Sales at Dalmore, I have the opportunity to work with hundreds of founders on a quarterly and annual basis. For me, the why is really being able to work with passionate entrepreneurs,” Santana said. “Being able to hear the story and the purpose and the issuer’s why gets me really excited.”

Santana then discussed how companies are raising capital online in the current environment.

“We've been a broker dealer for 20 years now, hyper focused in online fundraising, and that was really started through the JOBS Act, which introduced Regulation Crowdfunding (Reg CF), Regulation A+ and then, of course, Regulation D. Reg CF allows you to raise up to $5 million in capital from anyone over the age of 18 – both accredited and non-accredited investors can participate. The general population typically doesn't have access to these private investment opportunities. So, now, what we're finding is that these issuers are leveraging these tools to go out to the masses, raise capital in volume from the crowd and really bring on a sense of community.”

“Then, there’s Reg A+, which allows you to raise up to $75 million in capital. That’s really our focus at Dalmore. We've been fortunate enough to participate with some of the really significant offerings in the U.S. and over 50% of all Reg A+ filings, per KingsCrowd. Finally, there's Reg D, which is reserved for accredited investors only. Of course, that's a very popular and common path to raise capital. Some of our issuers are leveraging CF, A+ and D concurrently in different strategies. At a high level, those are some of the exemptions that we're focused on and how issuers are leveraging them.”

Join IBN’s Jonathan Keim and Bell2Bell’s latest guest to learn more about the ways that issuers can increase the cost-effectiveness and predictability of the capital raising process.

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: https://IBN.fm/Disclaimer

Bell2Bell’s latest podcast features Elnaz Sarraf, Founder & CEO of ROYBI, the creator of children’s intelligent educational robots and digital content. 

To begin the interview, Sarraf discussed her motivation for founding ROYBI. 

“Before ROYBI, I spent 5-6 years with my first company, iBaby, which had baby monitors. I spent a lot of time with parents, getting to know their needs and pain points,” Sarraf said. “Education has always been something that would come up. They were even asking about educational lullabies for babies. From that point, I developed a huge passion for technology and education. So, I decided to start my new journey by founding a technology company that implements educational content. 

“Long story short, we did a lot of research in the market beginning in 2017. Finally, we came up with the idea for ROYBI Robot, an educational robot for kids ages 3-7. We focus on language learning, vocabulary acquisition and communication skills. We started the company in 2019, and we are now available in major retail stores. We also have some pilot programs with schools. I would say ROYBI really started as a passion, and we are also really focused on the impact of our work on children’s lives.” 

Sarraf then examined some of the key challenges presented in developing ROYBI and provided insight into how the company overcame them. 

“When you found a startup company, you face different kinds of challenges every day. We went into manufacturing at the end of 2019, and, by the time we launched the product in 2020, we hit the pandemic. Everything with the supply chain and manufacturing went crazy and caused so many other issues,” Sarraf explained. “Aside from that, in the beginning, fundraising was the biggest challenge. ROYBI Robot is a complicated product. It has voice-recognition technology, a hardware component and many other things that made it difficult to convince investors that this product is needed. We finally built a semi-functional prototype to show investors. This helped us raise $4.2 million in our seed round in 2019.” 

Bell2Bell’s latest podcast features Amir Reichman, CEO of BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV). BiondVax’s pipeline is based on an innovative platform technology of alpaca-derived nanosized antibodies, known as Nanobodies or NanoAbs, addressing infectious and autoimmune diseases with large unmet medical needs such as COVID-19, psoriasis, psoriatic arthritis, asthma and macular degeneration.

This appearance follows a December 2022 interview between Reichman and host Stuart Smith. To review the first part of the series, visit The Stock2Me Podcast.

To begin the latest interview, Reichman discussed the company’s recent achievements, as detailed in a letter to shareholders issued late last year.

“At the end of 2022, we did a round of financing and raised about $8 million. We also started the negotiations to in-license the next antibody from the Max Planck Institute – namely the antibody for targeting interleukin-17 (IL-17) for the treatment of psoriasis,” Reichman said. “We have now in-licensed the IL-17 nanobody. This is a highly promising drug.”

“If we look at the market, psoriatic patients today have several options for treatment. For example, plaque psoriasis patients have creams and other topical drugs, biologics and oral drugs… The topicals are not highly sophisticated drugs to say the least, and they come with a considerable profile of side effects. When a person needs to take steroids once in a while for an infection, they can tolerate it, but when you need to take steroids for an autoimmune disease with chronic inflammation, you create tolerance and deal with potential side effects… The biologics are highly potent, but they are restricted to moderate and severe cases of psoriasis; this accounts for only 15% of patients with psoriasis. The 85% that are left have to choose between drugs based on 1960s and 1970s technology. There hasn’t been much breakthrough in recent years to serve these patients.”

Bell2Bell’s latest podcast features Eli Assoolin, CEO of Newsight Imaging. The company develops advanced CMOS image sensor chips for 3D machine vision and spectral analysis. Newsight’s depth camera sensors for machine vision serve verticals such as mobile & metaverse, robotics, and automotive safety.

To begin the interview, Assoolin discussed his career and provided some background on Newsight Imaging’s planned business combination with special purpose acquisition company Vision Sensing Acquisition Corp. (NASDAQ: VSAC).

“I founded Newsight Imaging seven years ago with my partner, Eyal Yatskan. We both come from the semiconductor industry. We worked for years, mainly for a large American company’s Israeli branch, where we were a part of bringing the semiconductor from its relatively early stages in the ‘90s to a very, very important industry these days,” Assoolin stated. “About a year-and-a-half ago, we were looking at how to bring Newsight into its next phase – how to rebrand the company and land in the U.S. while making us a better choice for our customers. We came to the conclusion that we needed to go public somewhere. Eventually, Vision Sensing found us and submitted an offer to merge. Since then, we’ve been working together on a merger that’s expected to be completed soon.”

Please see full terms of use and disclaimers on the InvestorBrandNetwork website, applicable to all content provided by IBN wherever published or re-published: http://ibn.fm/Disclaimer

“Reunion Gold is a gold exploration company. Our activities are mainly focused around the Guiana Shield, which includes countries like French Guiana, Suriname and Guyana,” said Rick Howes, President & CEO of Reunion Gold Corp. (TSX.V: RGD) (OTCQX: RGDFF). “We’ve been well established in [Guyana], and the team that’s leading the company today includes individuals who have been based in the Guiana Shield for over 40 years now… It’s a relatively underdeveloped, underexplored region, and it has high prospectivity, as it forms the basis of a large greenstone belt, which is a very common [source] for gold deposits.”

Bell2Bell’s latest podcast features Dr. Mark Berger, Chief Medical Officer of Genprex Inc. (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients living with cancer and diabetes.

This episode was recorded live at the venue hosting the 2023 American Association for Cancer Research Conference for Molecular Targets and Cancer Therapeutics, one of the premier conferences in the field. The conference serves as a platform for researchers, clinicians, and industry professionals to present and discuss the latest breakthroughs in cancer research.

Dr. Berger provided valuable insights into Genprex's recent groundbreaking achievements, particularly focusing on the promising data presented at the conference. He delved into the positive implications of the Acclaim-1 Phase 1 study, shedding light on the absence of Dose Limiting Toxicity and the potential impact of REQORSA® in the treatment of non-small cell lung cancer (NSCLC). Additionally, he discussed the upcoming Acclaim-3 clinical trial and the preclinical data in small cell lung cancer (SCLC), highlighting its significance in advancing SCLC treatment.

To gain a comprehensive understanding of Genprex's recent milestones and its transformative impact on cancer treatment, be sure to tune in to this informative episode.

Bell2Bell’s latest podcast features Hank Wang, CEO of SUIC Worldwide Holdings Ltd. (OTC: SUIC), a provider of research and development, venture financing and investment for private and public companies.

To begin the interview, Wang provided an introduction to SUIC Worldwide Holdings and its business model.

“SUIC Worldwide Holdings targets opportunities to enhance and streamline existing supply chain and financial processes. SUIC is the majority and U.S. operating shareholder of Beneway Holdings Group, which is planning to file an S-1 for an IPO this year. Through its I.Hart Group subsidiary, Beneway operates 150 global chain and franchise locations of a variety of brands, and it is planning to replicate this unique brand model in the U.S.”

Wang then discussed his role with the company and those of the SUIC management team.

“I am the CEO of SUIC and have been the CEO of the I.Hart Group since 2018. Elena Lin is associate CFO of SUIC. She previously served as CEO of Monga Chicken. In 2015, she was recognized as one of Taiwan's Top 100 Managers of the Year. Elton Han is associate CTO of SUIC. He is also currently Director of Food and Beverage Development for the I.Hart Group.”

Wang next provided insight into SUIC’s global reach and client base.

“Our clients include top e-commerce companies, global listing companies and global hotel chains, among others. Our products export to the U.S., Canada, the U.K., Australia, Japan, Hong Kong and countries throughout Southeast Asia.”

Join IBN’s Stuart Smith and Hank Wang, CEO of SUIC Worldwide Holdings Ltd. (OTC: SUIC), to learn more about the company’s recent milestones and operational goals for 2024 and beyond.

To hear the episode and subscribe for future podcasts, visit https://podcast.bell2bell.com.

The latest installment of The Bell2Bell Podcast continues to reinforce IBN’s commitment to the expansion of its robust network of brands, client partners, followers, and the growing IBN Podcast Series. For more than 18 years, IBN has leveraged this commitment to provide unparalleled distribution and corporate messaging solutions to 500+ public and private companies.

To learn more about IBN’s achievements and milestones via a visual timeline, visit: https://IBN.fm/TimeLine

Bell2Bell’s latest podcast features the return of Mark Selby, CEO and Director of Canada Nickel Company Inc. (TSX.V: CNC) (OTCQX: CNIKF), a company working to advance the next generation of high quality nickel sulphide projects to feed the high growth electric vehicle and stainless steel markets.

To begin the interview, Selby discussed the company’s recent news release announcing the positive Bankable Feasibility Study for its Crawford Nickel Sulphide Project.

“It’s a major milestone for the company – $2.5 billion after-tax NPV, 17% IRR. When you include the additional carbon capture and storage tax credits that we think we’ll be able to get, that nudges the IRR up to 18%. This is for a project that’s going to be a 40-year mine life,” Selby said. “We’re the second-largest nickel reserve in the world, the second-largest nickel resource in the world and, if we were fully ramped-up today, we’d be the third-largest nickel-sulphide operation globally.”

“This is in a nickel market where more than 100% of the supply has effectively come from Chinese-controlled sources in Indonesia, most of which with a massive carbon footprint. Because of the host rock we have, in addition to producing all that nickel, as well as cobalt, palladium, platinum, iron and chrome, we will also have the ability to store 1.5 million tons of CO2, which would also make us one of the largest carbon storage facilities in the world. If you look at what our overall effective carbon footprint would be, it would be negative 30 tons of CO2. So, in today’s world where everyone is looking for low-carbon alternatives, we’re a negative carbon alternative in terms of nickel production.”

Selby then turned his attention toward recent updates relating to Canada Nickel Company’s other projects.

“Crawford is just the first project of what we think is an entire nickel district in Timmins, which is a very established mining camp with all the major infrastructure in place. We assembled a package of 20 different properties, each of which we believe has an ultramafic deposit. We’ve successfully tested nine of them; three of them have a larger target footprint than what we have with Crawford. We’ve been very happy with those results.”

Join IBN’s Stuart Smith and Mark Selby, CEO and Director of Canada Nickel Company Inc. (TSX.V: CNC) (OTCQX: CNIKF), to learn more about the company’s recent milestones relating to the Crawford project and the development of its IPT Carbonation process, as well as its goals for the balance of 2023 and beyond.

To hear the episode and subscribe for future podcasts, visit https://podcast.bell2bell.com.

In this engaging episode, David Hough shared key updates following PaxMedica's recent meeting with the FDA, highlighting pivotal achievements such as:

• FDA discussion of PaxMedica's data from the PAX-HAT 301 Study and comprehensive nonclinical programs.
• PAX-HAT-301 study confirmed as positive evidence for African Sleeping Sickness treatment, expected to result in substantial time and resource savings for PaxMedica.
• FDA acknowledgment of PaxMedica's comprehensive nonclinical program, including safety pharmacology, ADME, and toxicology studies.
• Waivers granted for the thorough QT/QTc studies, affirming data relevance to the patient population.
• 2024 NDA submission anticipation underscores PaxMedica's commitment to neglected tropical disease treatments.

Bell2Bell’s latest podcast features Mark Selby, Chairman, CEO and Director of Canada Nickel Company Inc. (TSX.V: CNC) (OTCQX: CNIKF), a company working to advance the next generation of high quality nickel-cobalt projects to feed the high growth electric vehicle and stainless steel markets.

To begin the interview, Selby provided an introduction to the company’s business model and operating markets.

“Canada Nickel Company was founded just over three years ago. In that very short timeframe, we’ve taken a project from drillhole to one of the largest nickel-sulfide discoveries ever and the largest since the early 1970s,” Selby said.

Bell2Bell’s latest podcast features an update from Chase Edgelow, Co-Founder and CEO of EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF), Canada’s renewable natural gas infrastructure platform. 

To begin the interview, Edgelow provided a refresher on the company’s business model and operating markets. 

“EverGen is a renewable natural gas infrastructure platform. We develop, own and operate renewable natural gas facilities – facilities that take organic waste on the frontend, capture the methane that is produced as the waste decomposes and sell that methane as a form of green energy into local gas utilities, providing them significant carbon-negative fuel,” Edgelow said. “That’s what’s really exciting. We operate at the crux of two sustainable drivers in the North American market – a reduction of waste that creates harmful emissions and providing a source of green energy.” 

Bell2Bell’s latest podcast features Dr. Mark Berger, Chief Medical Officer of Genprex Inc. (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients living with cancer and diabetes.

This episode was recorded live at the venue hosting the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, the largest clinical oncology meeting of the year. Last year, there were 30,000 attendees at the meeting and another 12,000 tuning in electronically. This year’s event is estimated to be the same in size. 

Dr. Berger explained why this year has been such a great one for Genprex. To hear an exciting summary of the company’s recent accomplishments and his expectations for the future, tune into this episode. 

Bell2Bell’s latest podcast features Tyrone Docherty, President & CEO of First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF), a company committed to exploring for and providing essential and critical metals, including tellurium, gold, silver, copper and tungsten, for North American markets. 

To begin the interview, Docherty provided an introduction to the company’s business model and operating markets. 

“First Tellurium has a wonderful, high-grade gold and silver property in Canada, but it comes with this unique mineral, Tellurium, which is listed by both the United States and Canadian governments as critical,” said Docherty. “Tellurium has come into the fore over the last couple of decades, because it is used in solar panels by U.S. corporation First Solar, which uses a mixture of cadmium and tellurium, as opposed to different solar panels coming out of China. Tellurium is very important there, and it’s a very rare metal.” 

Bell2Bell’s latest podcast features Jose Gabriel Diaz, CEO of Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ), a global infrastructure and holding company in the cannabis industry.

To begin the interview, Diaz provided an introduction to MedCana and its business model.

“We are a U.S.-based holding company focused on developing infrastructure and cannabis companies around the world,” Diaz said. “Right now, the focus is primarily on markets outside of the U.S. that have already fully legalized pharmaceutical (and possibly some recreational) cannabis. We're looking at Switzerland, Germany, Portugal, Spain and most of Europe, as well as Australia, Brazil, Argentina and Uruguay… Our focus, initially, is not going to be into the United States, until there is a 100% guarantee that everything we’re doing is on the legal side.”

“The focus is for MedCana to develop these companies that we’ve acquired outside of the U.S. to grow a presence in these international markets. It's not just cultivation that we're doing, however. MedCana is an infrastructure company. We also have two other very important companies. One is focused on software to make sure that certifications are being managed by our companies, but not just our companies. These are software products that we will be selling to other companies as we develop them.”

“We also are very focused on infrastructure development of not just cannabis but technology in agriculture. Cannabis requires a tremendous amount of technology, greenhouses, irrigation and control systems. Instead of us purchasing from another company, we decided to take a majority stake in an established Colombian company that is already exploding… So, it’s developing these markets for the companies that we bought with the licenses. It's also focusing on infrastructure and software, along with the electronic resource planning and software management of these companies.”

Join IBN’s Stuart Smith and Jose Gabriel Diaz, CEO of Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ), to learn more about MedCana’s leadership team, as well as its recent milestones and operational goals for 2024.

To hear the episode and subscribe for future podcasts, visit https://podcast.bell2bell.com.

Bell2Bell’s latest podcast features Bryan McLaren, Chairman and CEO of Zoned Properties Inc. (OTCQB: ZDPY), a technology-driven property investment company focused on acquiring value-add real estate within the regulated cannabis industry.

To begin the interview, McLaren provided an introduction to Zoned Properties and its business model.

“Zoned Properties, based in Scottsdale, Arizona, is focused on real estate and the regulated cannabis industry. Zoned Properties is essentially a technology-driven property investment company. We look at state-by-state markets that have legalized and regulated cannabis – that's a huge emerging and growing industry.”

“Our company and our team go into these state marketplaces, and we identify, qualify and get these properties approved that can be utilized as regulated cannabis facilities. In the best-case scenario, what we're doing is securing a piece of retail real estate –an old bank, an old restaurant, an old quick service retail location – getting that property approved to be used as a cannabis site called a retail dispensary and leasing that property out to a third-party tenant with a cannabis license in that location under a long-term lease agreement.”

McLaren next discussed his background prior to joining Zoned Properties.

“I’ve been working in the regulated cannabis space as a real estate developer for 10 years now. There were only a couple of states with legalized cannabis back then. Now, we have 38 states in this country that have legalized either medical or full recreational adult use cannabis. We’ve come a long way in the past decade. Prior to that, I spent my early career focused on community development and real estate. I worked on many sustainable development projects, zero waste projects, wind turbines and solar field installations… It takes a lot of planning and organization on these very complex projects to get approvals. That experience translates perfectly into the regulated cannabis space.”

Join IBN’s Stuart Smith and Bryan McLaren, Chairman and CEO of Zoned Properties Inc. (OTCQB: ZDPY), to learn more about the company’s management team, as well as its recent milestones and operational goals for 2024 and beyond.

To hear the episode and subscribe for future podcasts, visit https://podcast.bell2bell.com.

The latest installment of The Bell2Bell Podcast continues to reinforce IBN’s commitment to the expansion of its robust network of brands, client partners, followers, and the growing IBN Podcast Series. For more than 18 years, IBN has leveraged this commitment to provide unparalleled distribution and corporate messaging solutions to 500+ public and private companies.

Bell2Bell’s latest podcast features Joe Onyero, Founder and CEO of Bebuzee Inc. (OTC: BBUZ), a social platform and streaming service focused on development and deployment of America's first superapp.

To begin the interview, Onyero introduced Bebuzee’s business model.

“Bebuzee is going to be launching the first superapp in the U.S. and Europe,” he said. “I'm sure a lot of people don't understand what I mean when I say superapp, so I’ll give an example. In Asia, they have a superapp called WeChat. It has a market cap of over $300 billion. The app has everything. Most social media users have video sharing apps, messaging apps and different sorts of apps on their phones. What a superapp does is give you one app that covers everything.”

“Instead of downloading 15-20 apps, you can have one superapp that does everything. It makes it easier. People are tired of jumping from one app to another. Bebuzee’s super app is going to do almost everything for you; it’s incredible. We’ve just finished it, and we’re preparing and getting all the infrastructure ready to launch globally.”

Onyero then discussed his background prior to founding Bebuzee.

“I have been in the social media industry for a very long time. In 2004, seven of my friends and I created a messaging service in Cambridge, U.K., but we didn’t launch it. After a couple of years, one of the big social media platforms in the U.S. launched something similar to what we created two years before. We were kicking ourselves. In 2012, I started putting ideas together, something that I see as the modern-day social networking platform. That was when Bebuzee was born… A superapp is very difficult to develop, but we never anticipated that it would take this long. That’s why we're so delighted that the superapp was completed at the end of 2023. That's a huge achievement.”

Join IBN’s Stuart Smith and Joe Onyero, Founder and CEO of Bebuzee Inc., to learn more about the company’s recent milestones, as well as its operational goals for the balance of 2024 and beyond.

To hear the episode and subscribe for future podcasts, visit https://podcast.bell2bell.com.

The latest installment of The Bell2Bell Podcast continues to reinforce IBN’s commitment to the expansion of its robust network of brands, client partners, followers, and the growing IBN Podcast Series. For more than 18 years, IBN has leveraged this commitment to provide unparalleled distribution and corporate messaging solutions to 500+ public and private companies.

Bell2Bell’s latest podcast features Steffan Dalsgaard, President and CEO of Golden Triangle Ventures Inc. (OTC: GTVH), a multifaceted consulting company pursuing ventures in the health, entertainment and technology industries.

To begin the interview, Dalsgaard provided an introduction to Golden Triangle Ventures and its business model.

“Golden Triangle Ventures is a conglomerate of holdings with operations in health and technology, and our recent focus is the entertainment space… We recently purchased about 70 acres, and we acquired one of the largest event developers in the country, ABI Create. We made a plan to build our own venue and develop a project called Destino Ranch, which will ultimately become a tourist attraction, large immersive art installation, music festival venue and, really, a destination center about an hour outside of Las Vegas.”

Bell2Bell’s latest podcast features Steven Dresner, CEO of Walk-in Dermatology, a modern, patient-focused dermatology practice.

During the interview, Dresner discussed Walk-in Dermatology’s mission and vision. 

“Walk-in Dermatology is really a cross between traditional dermatology and urgent care. The concept is very straightforward. In dermatology and other areas of medicine, patients tend to wait too long to be seen by a medical provider. We are focused on providing high-quality, same-day care. The services we perform are the exact same as you would find in a more traditional dermatology practice, but we are making those services more accessible to people who want a same-day appointment or just want to walk in… If you wake up with a rash or acne or some other issue and your dermatologist can’t see you for two months, that’s not going to help you very much. That’s the market that we serve.”

Join IBN’s Carmel Fisher and Steven Dresner, CEO of Walk-in Dermatology, as they discuss how Walk-in Dermatology’s economics compare to traditional practices, including metrics like patient acquisition cost and visit frequency.

Please see full terms of use and disclaimers on the InvestorBrandNetwork website, applicable to all content provided by IBN wherever published or republished: https://ibn.fm/Disclaimer

Bell2Bell’s latest podcast features Brian J. Esposito, CEO of Diamond Lake Minerals Inc. (OTC: DLMI), a multi-strategy operating company offering traditional investors an entry point to the future of digital securities.

To begin the interview, Esposito discussed DLMI’s business model and operating markets.

“The best way I can describe what we’re building here at DLMI is an old-school General Electric/Berkshire Hathaway approach where we’re going to have an umbrella holding company of all of these wonderful subsidiaries across multiple industries,” Esposito said. “Think of us as an industry-agnostic holding umbrella company with wonderful entities that we build, start or acquire. The idea is strong, consistent earnings; shareholder value; and sharing those earnings with our shareholders through strong, consistent dividend distribution. I’m a strong believer that this is what’s needed in the market… I’m proud to be here as the CEO since late August. I’m proud of the accomplishments that we’ve achieved over the past few months, and the global support that we have is quite exceptional.”

Join IBN’s Stuart Smith and Brian J. Esposito, CEO of Diamond Lake Minerals Inc. (OTC: DLMI), to learn more about how the company’s leadership team, including President Michael Reynolds and Senior Transaction and Investment Executive Jon Karas, is working to drive growth, earnings and shareholder value in the months to come.

To hear the episode and subscribe for future podcasts, visit https://podcast.bell2bell.com.

Bell2Bell’s latest podcast features Mariano Soria, General Manager of Turbo Energy S.A., a leading photovoltaic energy storage technology company based in Valencia, Spain.

To begin the interview, Soria introduced Turbo Energy and its business model.

“Turbo Energy is part of a group with more than 20 years of experience in photovoltaic energy,” Soria said. “The company itself was born 10 years ago with the aim of introducing disruptive storage technology, mainly for off-grid homes that wanted to live with photovoltaic energy. It was the introduction of lithium-ion batteries in Spain, and it was also, for us, the beginning of Turbo Energy's leadership in Spain concerning photovoltaic energy storage.”

Bell2Bell’s latest podcast features Chairman, President and CEO Rodney Varner and CFO Ryan Confer of Genprex, Inc. (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients living with cancer and diabetes. 

In this interview, Varner and Confer discuss the journeys that led them to Genprex and the incredible promise of the company’s clinical drug development pipeline. 

“This work has become a real passion for me. We have the opportunity to do real good here at Genprex on a major scale – helping millions of people around the world with serious diseases through our novel gene therapies,” said Varner. 

Confer then provided some background on what led him to join Genprex in its early days and remain with the company for well over a decade. 

“As I learned more and more about the technology, it became a passion of mine, as well,” said Confer. “What we’re trying to do in cancer – using a lipid-based delivery vehicle and working with tumor suppressor genes that are naturally occurring in the body – represents a treatment paradigm that is unique and different than other options in the space, particularly chemotherapy that has such negative side effects. It is something that we believe really has the potential to change people’s lives as they’re going through such a terrible prognosis. I was excited then, and here we are 12 years later, being able to see it coming through clinical trials, seeing how safe the program has been and seeing the impact that we’re having.” 

Bell2Bell’s latest podcast features Wolf E. Regener, President and CEO of Kolibri Global Energy Inc. (NASDAQ: KGEI) (TSX: KEI), a North American energy company focused on finding and exploiting energy projects in oil and gas.

During the interview, Regener discussed Kolibri Global Energy’s efforts to sustain healthy margins despite oil price volatility. 

“It's all about the wells that we have drilled performing, but we have enough production history that it shouldn't be a big risk. We’re also drilling new wells, so there’s always some variability. Despite this, we try to be conservative in our forecasts and drill in proven locations to avoid taking big risks. We do have one well that we're drilling this year that has a higher risk profile. We have a 46% interest in that project, and a large integrated oil company is our partner—people can probably figure out who that is. That partnership reduces some of our risk and enables us to prove up even more reserves, because those are not in our reserve report right now. That's another 3,000 acres that we could potentially prove up economically.”

Join IBN’s Carmel Fisher and Wolf E. Regener, President and CEO of Kolibri Global Energy, as they discuss the company’s strategic approach to location prioritization. 

Please see full terms of use and disclaimers on the InvestorBrandNetwork website, applicable to all content provided by IBN wherever published or republished: https://ibn.fm/Disclaimer

Bell2Bell’s latest podcast features Howard Weisman, Chairman and CEO of PaxMedica, Inc. (Nasdaq: PXMD), along with Buzz Woods from Corporate Communications, who join the podcast to share insights into the biopharmaceutical company's groundbreaking work in novel anti-purinergic drug therapies (APT) for neurologic conditions, primarily Autism Spectrum Disorder (ASD).

Explore the comprehensive interview on the Bell2Bell Podcast, where PaxMedica, Inc., a prominent clinical-stage biopharmaceutical firm, provides valuable perspectives on its innovative initiatives and visionary advancements in the sphere of novel anti-purinergic drug therapies. Gain an exclusive understanding of PaxMedica's pioneering efforts in neurology and biopharmaceutical breakthroughs, with a special emphasis on advancements in treating Autism Spectrum Disorder (ASD) and other neurologic conditions, as Howard Weisman, Chairman and CEO, and Buzz Woods from Corporate Communications, offer a compelling overview of the company's recent achievements and future objectives.

Join the highly acclaimed host, Bell2Bell's Stuart Smith, and Howard Weisman, Chairman and CEO of PaxMedica, Inc. (Nasdaq: PXMD) and Buzz Woods Corporate Communications, to learn more about the company’s recent milestones and operational goals for the balance of 2023 and beyond.

Bell2Bell’s latest podcast features Nicholas Lemieux, Founder & CEO of Athlete Studio, the premier eCommerce and marketing automation platform for professional athletes. Athlete Studio handles everything for athletes looking to create custom merchandise, mint digital collectibles and connect with their fans and communities.

Throughout the interview, Lemieux discussed Athlete Studio and how it is addressing the various issues facing sports figures and athletes who want to connect with their fans and be able to market goods and collectibles.

“The initial idea for Athlete Studio was to build content-based automation software for API-based content automation software, using data from ESPN, social media platforms or YouTube to automate the creation of websites, email newsletters and other tedious marketing tasks that every influencer and athlete has to do manually,” Lemieux said.

Bell2Bell’s latest podcast features Dr. Marshal Lemerani, Program Manager for the Malawi Ministry of Health and Howard Weisman, CEO of PaxMedica (NASDAQ: PXMD), a biopharmaceutical company dedicated to advancing treatments for neurological disorders, which takes center stage in the episode. During this insightful conversation, Howard Weisman, CEO of PaxMedica, and Dr. Marshal Lemerani, Program Manager at the Malawi Ministry of Health, joined host Stuart Smith to discuss the urgent request for medical assistance from Malawi and PaxMedica's swift response.

The podcast sheds light on PaxMedica's commitment to addressing the critical shortage of medications required to combat the life-threatening sleeping sickness crisis in Malawi. Weisman highlights the pressing need for IV suramin (PAX-101), a crucial medication in treating Trypanosoma brucei rhodesiense Human African trypanosomiasis (TBr HAT), and PaxMedica's immediate action plan to aid. Lemerani shares insights into the challenges faced by healthcare professionals in Malawi and expresses gratitude for PaxMedica's support in this dire situation.

To listen to the full podcast and learn more about PaxMedica's response to the urgent medical situation in Malawi, visit https://podcast.bell2bell.com.

The latest installment of The Bell2Bell Podcast continues to reinforce IBN’s commitment to the expansion of its robust network of brands, client partners, followers, and the growing IBN Podcast Series. For more than 18 years, IBN has leveraged this commitment to provide unparalleled distribution and corporate messaging solutions to 500+ public and private companies.

Bell2Bell’s latest podcast features Will Gray, Founding Partner, CEO & Director of New Era Helium Inc. (NASDAQ: NEHC), an exploration and production (E&P) company sourcing helium from natural gas reserves in the Permian Basin.

During the interview, Gray discussed New Era Helium’s mission and vision. 

“We are an upstream natural gas and helium producer that's focused within the Permian Basin. We own and operate approximately 137,000 acres hosting 400-plus wells with substantial proved and probable gas reserves that have helium associated with them… When you look at the number of publicly traded, small- and micro-cap, upstream helium companies, a lot of them are in the exploration stage. They have large acreage positions, but not yet commercialization. We’re actually producing helium and natural gas now… We're looking to vertically integrate with our own processing plants and our own infrastructure. That's really what we're doing as we speak. That's how we differentiate in the market. We offer a lower-risk scenario with proved helium reserves.”

Join IBN’s Carmel Fisher and Will Gray, Founding Partner, CEO & Director of New Era Helium, as they discuss the company’s efforts to develop a 250MW net-zero energy AI/HPC data center through a partnership with Sharon AI.

Please see full terms of use and disclaimers on the InvestorBrandNetwork website, applicable to all content provided by IBN wherever published or republished: https://ibn.fm/Disclaimer

Bell2Bell’s latest podcast features the return of Richard Clowater, President of GEMXX Corp. (OTC: GEMZ), a mine-to-market enterprise specializing in gold, gemstone and jewelry production.

To begin the interview, Clowater expounded on a recent news release detailing why the company’s management team feels GEMXX is currently undervalued.

“Since its inception, GEMXX has always looked for resource assets that are commercially viable. To date, we’ve acquired five properties, but only one of those properties has a partial assessment known as an S-K 1300, which is a report produced by a qualified professional,” Clowater explained. “These reports offer comprehensive insights into mineral resources, reserves, exploration, outcome and the technical intricacies of a project. That being said, the report is not required to determine if a property is a good acquisition – if you have enough mining experience.”

LOS ANGELES, September 24, 2024 (GLOBE NEWSWIRE) – via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The Bell2Bell Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels.

The Bell2Bell Podcast delivers informative updates and exclusive interviews with executives operating in fast-moving industries. Bell2Bell’s latest podcast features Vladi Delsoglio, CEO of Ederra, a farm-to-body wellness brand that combines nature and cutting-edge science to create innovative, functional supplements for brain and body longevity.

To begin the interview, Delsoglio discussed his personal journey and how it led to the founding of Ederra.

“I started Ederra after being diagnosed with fatty liver disease, when I realized that traditional treatments weren't enough. When the doctor told me that I had a non-alcoholic fatty liver disease, it was a shock to me. I’ve always had an amazing, healthy lifestyle – no smoking, drinking one or two beers per week and cooking all my meals. My doctor suggested that I incorporate broccoli microgreens into my diet. When I did that, my liver got better. From there, I start chatting with doctors, scientists and farmers in San Diego County. A year later, we launched EMPWR+, Ederra’s flagship product.”

“The name of the company, Ederra, comes from a Basque word meaning that everything surrounding you is beautiful. When you are happy with yourself, when you are healthy, when you have a healthy lifestyle, then everything surrounding you is beautiful. The EMPWR+ brand is named for the extra kick it gives to your daily routine. Our tagline is ‘Your wellness, your routine, your way’.”

“EMPWR+ is a farm-to-body functional superfood supplement featuring broccoli microgreens and Lion’s Mane mushrooms. Broccoli has a very potent antioxidant longevity compound called sulforaphane. Inside the broccoli microgreens featured in EMPWR+, this compound is 50 to 100 times more potent. It’s super powerful and really helps on anti-inflammatory, detox, anti-cancer and so forth. We add Lion’s Mane mushrooms for brain health. We wanted to create a very simple, two-ingredient, super powerful supplement that helps your body as well as your brain.”

Join IBN’s Carmel Fisher and Vladi Delsoglio, CEO of Ederra, to learn more about the company’s farm-to-body approach to its products and how that approach differentiates Ederra in the supplement industry.

To hear the episode and subscribe for future podcasts, visit https://podcast.bell2bell.com.

The latest installment of The Bell2Bell Podcast continues to reinforce IBN’s commitment to the expansion of its robust network of brands, client partners, followers, and the growing IBN Podcast Series. For more than 18 years, IBN has leveraged this commitment to provide unparalleled distribution and corporate messaging solutions to 500+ public and private companies.

To learn more about IBN’s achievements and milestones via a visual timeline, visit: https://IBN.fm/TimeLine

About Ederra

Ederra creates farm-to-body functional superfood supplements designed to help people live healthier, more vibrant lives. The company caters to visionaries, entrepreneurs, explorers and those who push boundaries. Ederra’s products also serve our most cherished individuals – sisters, brothers, friends and mothers.

Ederra tackles challenges with diverse perspectives, unified by a shared passion for nutrition, sustainability and making the world a better place. To deliver the quality supplements its customers deserve, Ederra revolutionized production through local neighbor farms. The company’s dedication to freshness, quality and sustainability isn’t just about being premium; it’s about making a positive impact on the world.

For more information, visit the company’s website at www.EderraLyfe.com

About IBN

IBN consists of financial brands introduced to the investment public over the course of 18+ years. With IBN, we have amassed a collective audience of millions of social media followers. These distinctive investor brands aim to fulfill the unique needs of a growing base of client-partners. IBN will continue to expand our branded network of highly influential properties, leveraging the knowledge and energy of specialized teams of experts to serve our increasingly diversified list of clients.

Through our Dynamic Brand Portfolio (DBP), IBN provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) Press Release Enhancement to ensure maximum impact; (4) full-scale distribution to a growing social media audience; (5) a full array of corporate communications solutions; and (6) total news coverage solutions.

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

Forward-Looking Statements

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company's SEC filings. These risks and uncertainties could cause the company's actual results to differ materially from those indicated in the forward-looking statements.

Corporate Communications

IBN Los Angeles, California www.InvestorBrandNetwork.com 310.299.1717 Office Editor@InvestorBrandNetwork.com

Bell2Bell’s latest podcast features Wa’el Hashad, CEO of Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (HLHS), Alzheimer’s disease and Aging-related Frailty.

To begin the interview, Hashad introduced Longeveron and its business model.

“Longeveron is a cell therapy-based biotech company. It was established in 2014 as a spin-off from a technology that was developed at the University of Miami School of Medicine by a renowned scientist and cardiologist, Dr. Josh Hare,” Hashad said. “Josh has been working since he graduated medical school… on trying to help patients regenerate their heart muscles after heart attacks. He continued to use stem cells – specifically mesenchymal stem cells, or medicinal signaling cells – to try to develop medicines that may help patients have a better outcome after heart attacks and so on.”

Bell2Bell’s latest podcast features Richard Clowater, President of GEMXX Corp. (OTC: GEMZ), a mine-to-market enterprise specializing in gold, gemstone and jewelry production.

To begin the interview, Clowater provided an introduction to Ammolite, an extremely rare gemstone of which GEMXX is a leading producer.

“Ammolite is a very rare gemstone. It’s similar to black opal when you look at it; it’s very iridescent and features a kaleidoscope of colors. You can actually find every color of the rainbow in a single gemstone,” Clowater explained. “The really interesting part about the gemstone is where it comes from. It’s the fossilized shell of a creature called an Ammonite, an ancient sea nautilus. Now, Ammolite gemstone and Ammonite fossils are only found along the eastern slopes of the Rocky Mountains in southern Alberta, Canada, fossilized into this beautiful gemstone. Because it’s only found in one place and it’s so highly sought-after, it’s considered to be one of the rarest gems on earth.”

Clowater then turned his attention to GEMXX’s business model and leadership team.

“GEMXX is a mine-to-market enterprise, and we aspire to be fully integrated. This means that we must wear a lot of hats in this business model. We’re a resource exploration company, and we have over $800 million in reserves. We currently mine gold, and we’re very excited to hopefully open the world’s largest Ammolite mine by the end of this year. After operating several mines in the area over the last 30 years, our experience will allow us to move quickly on that operation… We also manufacture all of our own products, and we’re a wholesaler of gold, finished gemstones and fine jewelry, as well as being a retailer of our finished products around the world in any areas that don’t have representation by our retailers.”

“All of us have been in the industry for a long time. We are grateful to have a management team with over 160 years of combined experience in gold, gemstone production, operations and sales. Our mining experts have decades of experience getting gold and Ammolite gemstone out of the earth, and mining Ammolite is no easy task… It’s our experts that provide a competitive edge in every facet of our business, allowing us to excel in product development, maintain rigorous quality control and maximize profitability.”

Join IBN’s Stuart Smith and Richard Clowater, President of GEMXX Corp. (OTC: GEMZ), to learn more about the company’s recent milestones and operational goals for the balance of 2023 and beyond.

Bell2Bell’s latest podcast features Brien Lundin, CEO of New Orleans Investment Conference and Editor of Gold Newsletter. The New Orleans Investment Conference, scheduled for November 1-3, 2023, brings together the world’s most sophisticated investors to discover new opportunities and strategies, exchange ideas, plan for the coming year and enjoy the camaraderie of like-minded individuals.

Throughout the interview, Lundin provided intriguing insights into the history of the New Orleans Investment Conference and highlights planned for this year’s event.

“The New Orleans Investment Conference is the longest-running investment event in the world today. This will be our 49th year,” Lundin said. “It has also earned a reputation over the years of being ‘The World’s Greatest Investment Event’. We’re known for bringing together speakers and experts, including some of the world’s leading thought-leaders in macroeconomics, various investment markets and even geopolitics.”

“Our stage has been graced by the likes of Lady Margaret Thacher, Ayn Rand, Milton Friedman and Alan Greenspan. The list goes on and on and features many of the giants of modern history, economics and geopolitics. This year, we have what I believe is the greatest lineup of experts in our history and, by extension, in the history of any investment event. We’ve got people who can explain the very unusual and extraordinary events that are going on in geopolitics and economics. Because of this extraordinary environment that we’re in right now, extraordinary thinkers have risen to the fore, and we’ve got them all.”

“Anybody who is a serious investor should attend the New Orleans Investment Conference, including anyone who is concerned about a world in which the levers of the economy are being pulled by central bankers almost exclusively… For anyone who believes that the coming events are either risks to their wealth or opportunities to build their wealth, both sides will be presented at our event. These are unusual times that we’re living through… and a number of things are going to be breaking in the days and weeks ahead. If you’re concerned about that, this is the place for you.”

Join IBN’s Jonathan Keim and Bell2Bell’s latest guest to learn more about the investment opportunities available to attendees of this well-recognized event series.

Please see full terms of use and disclaimers on the InvestorBrandNetwork website, applicable to all content provided by IBN wherever published or re-published: http://ibn.fm/Disclaimer

IBN, a multi-dimensional communications organization engaged in connecting public companies with the investment community, proudly announces the airing of a new episode of The Bell2Bell Podcast. This podcast is part of IBN's extensive effort to provide specialized content through widespread syndication channels. The Bell2Bell Podcast is known for its informative updates and exclusive interviews with top executives in rapidly evolving industries.

The latest episode features a comprehensive interview with Dr. Tri T. Nguyen, the Co-Founder and CEO of Astiva Health. Astiva Health is rapidly making its mark in the Medicare Advantage Prescription Drug (MAPD) sector with its commitment to transforming personalized and comprehensive healthcare.

During the interview, Dr. Nguyen offered insights into Astiva Health’s foundations and its unique business model. “Astiva was established in 2020, with our operations commencing on January 1, 2021, in Orange County and San Diego,” explained Dr. Nguyen. “Recently, we've expanded our services to Los Angeles, San Bernardino, and Riverside, starting January 1, 2024. The name Astiva blends ‘ast’ — an old English, Nordic, and German word meaning ‘love’ or ‘enjoy’ — with ‘viva,’ meaning ‘life.’ It encapsulates our philosophy of loving life, which is central to our healthcare approach.”

Dr. Nguyen, with his extensive medical background from esteemed institutions such as Stanford Medical School, UC Davis, and UC San Diego, shared how his experiences influence Astiva’s direction. “In my over 25 years of medical practice, I’ve realized that effective healthcare hinges largely on patient involvement. It's about active participation rather than passivity. At Astiva, we emphasize this in our care approach, leading to healthier lives and reduced medical costs. Leveraging technology and efficient operations as a startup, we've been able to reinvest savings into rich supplemental benefits for our members.”

This latest Bell2Bell Podcast episode with Dr. Nguyen provides an in-depth look at how Astiva Health is reshaping healthcare delivery. It underscores the importance of patient involvement in healthcare and highlights Astiva Health's innovative strategies in offering comprehensive care.

To hear Dr. Nguyen's full interview and gain more insights into Astiva Health's journey and vision, visit https://podcast.bell2bell.com.

The latest installment of The Bell2Bell Podcast continues to reinforce IBN’s commitment to the expansion of its robust network of brands, client partners, followers, and the growing IBN Podcast Series. For more than 17 years, IBN has leveraged this commitment to provide unparalleled distribution and corporate messaging solutions to 500+ public and private companies.

To learn more about IBN’s achievements and milestones via a visual timeline, visit: https://IBN.fm/TimeLine

Bell2Bell’s latest podcast features Rob Etherington, President and CEO of Clene Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases.

To begin the interview, Etherington provided an introduction to Clene’s business model and discussed recent developments providing hope to those affected by neurodegenerative conditions.

“Clene spends every waking moment working on amyotrophic lateral sclerosis (ALS), a devastating neurodegenerative condition. We are focused on neurodegenerative diseases generally – including multiple sclerosis and Parkinson’s – but our body of evidence that has really come to the forefront in the last few years has been all around ALS,” Etherington explained. “The timing is important because this remains a remarkably devastating disease with life mortality of 3-5 years from diagnosis. It remains uniformly and universally fatal… It’s just devastating and tragic.”

Bell2Bell’s latest podcast features Mark Emerson, President and CEO of AiEnglishGPT, an AI-driven platform providing personalized, real-time language and professional skills instruction across 64 languages.

During the interview, Emerson discussed AiEnglishGPT’s business model. 

“We are breakthrough technology for education. We’ve created what we call the super teachers – synthetic humans that look very lifelike and have a ton of content knowledge. They become your personal teachers, educating you on whatever you or your child needs to learn, whether it be algebra, a new language or just homework… We are a proprietary system. What is really unique is the amount of content that we have being translated into the end users’ languages. We can truly provide, basically, a teacher that’s communicating with the students in Vietnamese, Russian, Spanish, etc., giving them their own personal tutor. That’s never been done before by anyone, and we’re excited to be the pioneers.”

Join IBN’s Carmel Fisher and Mark Emerson, President and CEO of AiEnglishGPT, as they discuss the company’s plans to address needs in both B2C and enterprise markets.

Please see full terms of use and disclaimers on the InvestorBrandNetwork website, applicable to all content provided by IBN wherever published or republished: https://ibn.fm/Disclaimer

Bell2Bell’s latest podcast features Thomas Ullrich, CEO of Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF), a publicly traded Canadian minerals exploration company focused on exploring high-grade copper and gold deposits in North America.

To begin the interview, Ullrich provided an introduction to Aston Bay and its business model.

“Overall, Aston Bay is in the business of adding value through discovery of high-grade critical metals and precious metals deposits. We're an exploration stage company. Really what that means is that we want to get out there and make those first finds – really make the discovery – because we think that's where you add the most value over the shortest period of time for our shareholders.”

Ullrich then discussed his background and those of the Aston Bay team.

“I’ve been in geoscience since the early '90s working in everything from big mining companies to universities, as well as the junior exploration space, which is where I am now and where I prefer to be. I think this is the most exciting place to be. There’s nothing more exciting than making a discovery.”

“As far as the company goes, it's an extremely small company. I am CEO, and I'm really the only full -time employee of this company, but we do have a fantastic group of advisors and directors. Jessie Liu-Ernsting, who has been with Aston Bay for several years now, has fantastic capital markets experience and decades in the business. Jeff Wilson is the CEO of Precipitate Gold and has experience with multiple private and public companies in the space. Mark Pryor is a very experienced exploration geologist and the current Vice President of Exploration for The Electrum Group, a very well-respected group in the exploration and development space. Last but not least is Gary O’Connor, another extremely experienced geologist who has spent a lot of time in the capital markets as well.”

Join IBN’s Stuart Smith and Thomas Ullrich, CEO of Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF), to learn more about Aston Bay’s recent milestones and operational goals for 2024 and beyond.

To hear the episode and subscribe for future podcasts, visit https://podcast.bell2bell.com.

Bell2Bell’s latest podcast features Corrado De Gasperis, Director, Executive Chairman, and CEO of Comstock Inc. (NYSE American: LODE), a developer of technologies to transform waste and under-utilized resources into renewable fuels and electrification metals.

During the interview, De Gasperis discussed Comstock’s business model. 

“In recent years, we’ve developed technologies that convert waste wood and other lignocellulosic materials into extremely low-carbon liquid fuels, including renewable diesel and sustainable aviation fuels. Additionally, we’ve perfected a process for recycling waste electrification products, such as solar panels, by eliminating contaminants and enabling the reuse of all materials in new products. This includes clean aluminum, glass, silver-rich, and mineral-rich tailings, all repurposed to achieve a certified zero-landfill solution. It’s a win-win – excellent for the environment and highly profitable for reusing these critical materials.”

Join IBN’s Carmel Fisher and Corrado De Gasperis, Director, Executive Chairman, and CEO of Comstock, to learn more about the company’s recent milestones and value proposition for investors.

Please see full terms of use and disclaimers on the InvestorBrandNetwork website, applicable to all content provided by IBN wherever published or re-published: http://ibn.fm/Disclaimer

Bell2Bell’s latest podcast features Martin Kostuik, CEO and Director of Battery Mineral Resources Corp. (TSX.V: BMR) (OTCQB: BTRMF), a battery minerals company providing shareholders exposure to the global mega-trend of electrification while being focused on growth through cash-flow, exploration and acquisitions in favorable mining jurisdictions.

To begin the interview, Kostuik provided an introduction to the company’s business model and operating markets.

“Battery Mineral Resources is a development-style junior mining company operating in North America and around the world. We have properties that represent the major commodities involved with the energy transition that everybody understands and sees affecting all of our lives all around the world,” Kostuik said. “We’re very pleased to be able to offer our shareholders exposure to this electrification trend via our commodities, which are cobalt, graphite, lithium and copper.”

Bell2Bell’s latest podcast features Nicole Brewster, President and CEO of Renforth Resources Inc. (CSE: RFR) (OTCQB: RFHRF), an active mineral exploration company engaged in the exploration and development of its wholly owned multi-commodity mineral properties in Canada.

During the interview, Brewster discussed Renforth’s business model and value proposition for investors. 

“Renforth is a multi-commodity junior exploration company. We're comprised of a number of retail shareholders who repeatedly support the company as they align with our vision of developing our multi-metals package, which includes a 275-square-kilometer, extremely well-located property in Quebec. This property contains a significant amount of nickel mineralization along with an appreciable amount of zinc. Very close by, we also have our Parbec gold deposit, which anchors the company's value because we know how many ounces of gold are in the ground.” 

“In fact, we're in the midst of redoing the Parbec resource based on a significant amount of information that's come to light subsequent to the historic 2019 resource. The most basic change is that, when the historic resource was calculated, the price of gold was $1,450 an ounce. It's now pushing $2,700 an ounce, so the value of our gold deposit has, even without the addition of our new information, appreciably increased.” 

“That's us in a nutshell – two very compelling assets that give us both financial anchor and exposure into the energy transition world. They both benefit from roads, hydroelectric power, supportive communities, and established mining camps. All of this is in a little junior company that, in Canadian terms, trades for a penny and a half... We're in the heart of gold country in Quebec, and arguably in Canada. We're on one of the most prolific, financially important gold structures that runs for a couple of hundred kilometers, and our foothold here is very compelling.” 

Join IBN’s Carmel Fisher and Nicole Brewster, President and CEO of Renforth Resources, to learn more about the company’s strategy for assessing and prioritizing commodities and properties. 

Please see full terms of use and disclaimers on the InvestorBrandNetwork website, applicable to all content provided by IBN wherever published or re-published: http://ibn.fm/Disclaimer

Bell2Bell’s latest podcast features Ross Sklar, CEO of Starco Brands, Inc. (OTCQB: STCB), a company with an unwavering mission to invent and acquire consumer products and brands with behavior-changing technologies that spark excitement in the everyday.

To begin the interview, Sklar provided an introduction to the company’s business model and operating markets.

“Starco Brands is focused in consumer products. We really think of ourselves as a modern-day invention factory. We look for places in the marketplace that we think have a tremendous amount of white space,” Sklar said. “From a formulary vantage point, we came out of industrial products… I was innovating in that sector for a long time and had some pretty significant success. I then found my way into consumer products, and we started to play in household, personal care, OTC pharmaceuticals, beverages and spirits. We’re very well diversified, but the main thing is that we think we’ve got strong capabilities in developing intellectual property… by curating brands and owning them… The other side is that we’ve executed and are executing an interesting, like-minded acquisition model.”